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Abstract: 
Mutants created by site-directed mutagenesis were used to elucidate the function of amino acids involved in 
ligand binding to ecdysteroid receptor (EcR) and heterodimer formation with ultraspiracle (USP). The results 
demonstrate the importance of the C-terminal part of the D-domain and helix 12 of EcR for hormone binding. 
Some amino acids are involved either in ligand binding to EcR (E476, M504, D572, I617, N626) or ligand-
dependent heterodimerization as determined by gel mobility shift assays (A612, L615, T619), while others are 
involved in both functions (K497, E648). Some amino acids are suboptimal for ligand binding (L615, T619), 
but mediate ligand-dependent dimerization. We conclude that the enhanced regulatory potential by ligand-
dependent modulation of dimerization in the wild type is achieved at the expense of optimal ligand binding. 
Mutation of amino acids (K497, E648) involved in the salt bridge between helix 4 and 12 impair ligand binding 
to EcR more severely than hormone binding to the heterodimer, indicating that to some extent 
heterodimerization compensates for the deleterious effect of certain mutations. Different effects of the same 
point mutations on ligand binding to EcR and EcR/USP (R511, A612, L615, I617, T619, N626) indicate that 
the ligand-binding pocket is modified by heterodimerization. 
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Article: 
Introduction 
Besides molting and metamorphosis, ecdysteroids regulate many aspects of development, differentiation, 
reproduction and behavior during the life cycle of arthropods. To date more than 100 genes have been reported 
to be regulated by ecdysteroids and depend upon the tissue, the developmental stage and the gene (Thummel, 
1995; Spindler-Barth and Spindler, 2000; Spindler et al., 2001). Elucidation of the molecular mechanism of 
ecdysteroid action is therefore a central part in understanding the hormonal control of arthropod development 
(Koelle et al., 1991; Lezzi et al., 1999). 
 
The ligand-binding domain (LBD) of nuclear receptors exhibits multiple functions and mediates the hormonal 
control of dimerization and transactivation. Hormone binding to EcR is modulated by the dimerization partner 
(Vögtli et al., 1999; Grebe et al., 2002) and receptor activity is further influenced by the cellular context (Elke et 
al., 1999; Lan et al., 1999). 
 
A number of ecdysteroids were tested with different bioassays and ligand binding studies (Cherbas et al., 1980; 
Dinan, 1989), which allowed a detailed mapping of the structurally essential parts of the ligand, by CoMFA 
(Dinan et al., 1989). Species-specific differences in the amino acid sequence of the ecdysteroid receptor 
(Mouillet et al., 1997; Suhr et al., 1998), characterization of truncated receptors (Perera et al., 1999; Lezzi et al., 
2002), and the use of chimeric proteins (Henrich et al., 2000) gave some hints on the functional importance of 
selected amino acids or receptor domains. 
 
In contrast to vertebrate steroid hormone receptors, no crystallographic data of the ligand-binding pocket of the 
ecdysteroid receptor are available, and the sequence identity of EcR to vertebrate nuclear receptors is only 
modest (28% to TRß and 25% to RAR; Koelle et al., 1991). Based on a generalized model of nuclear receptors 
(Wurtz et al., 1996, 2000), Wurtz et al. (2000) used VDR and RAR as templates to propose a three-dimensional 
structure of the ligand-binding domain of EcR. From the proposed model, the amino acids lining the ligand-
binding pocket and presumably involved in ligand binding were predicted. 
 
Ligand binding and dimerization mutually influence each other. From vertebrate nuclear receptors, it is known 
that receptor functions are modified allosterically by intra- and intermolecular interactions (Antoniewski et al., 
1996; Doesburg et al., 1997; Scheller et al., 1998; Kumar et al., 1999). In this study we characterized hormone 
binding and dimerization of the ligand-binding domain of the Drosophila EcR and in recombinant, mutated 
receptors in the absence and presence of the most important dimerization partner, ultraspiracle. 
 
Results 
To identify amino acids involved in dimerization and hormone binding, the ligand-binding domain, including 
part of the hinge region of EcR and USP, coupled to Gal4-AD and Gal4-DBD (Figures 1 and 2) was 
characterized. Various truncated forms and point mutations of EcR were tested with gel mobility shift assays 
and hormone binding experiments. 
 
   
Characterization of the Wild-Type Ligand-Binding Domains 
Heterodimers of full-length EcR and USP interact with responsive elements already in the absence of hormone, 
but binding is enhanced after addition of hormone (Figure 3A) as described previously (Antoniewski et al., 
1996; Vögtli et al, 1998; Elke et al., 1999). With Gal4(DBD)- USP(172–508), the expected protein-DNA 
complex is seen using a Gal4 specific UAS (Figure 3A). No heterodimer is formed in the presence of 
GAl4(AD)- EcR(375–652) if hormone is omitted. In the presence of 10
–5
 M muristerone A, a shifted band is 
visible indicating that only ligand dependent heterodimerization is detected under these conditions. The molar 
ratio of USP/EcR is critical for dimerization as shown in Figure 3B. 
   
 
Wild-type, full-length receptors of Drosophila, obtained by in vitro transcription/translation (Vögtli et al., 
1999), and fusion proteins containing only the C-terminal part of the hinge region and the LBD of EcR, interact 
with ponasterone A in the same way (Figure 4A, B). In both cases hormone already binds to a small, but 
significant degree in the absence of USP. In the presence of USP, ligand binding to EcR increases as much as 
10-fold (Figure 4C). 
 
To ensure optimal receptor concentrations, EcR- and USP-fusion proteins were expressed separately and their 
concentrations in yeast extracts were checked by quantitative evaluation of Western blots (Figure 5A), using a 
standard curve with wild-type receptor domains (Figure 5B). 
 
    
 
 
In the following ligand binding experiments and EM-SAs, the same ratio of receptor concentrations that was 
necessary to obtain maximal ligand binding of the wild-type heterodimer (10-fold increase compared to 
hormone binding to EcR) was used for all mutants. This standardization excludes the possibility of low ligand 
binding or dimerization, due to suboptimal concentrations of EcR and USP, being misinterpreted as a reduced 
ability for heterodimerization or hormone binding for EcR/USP. Since the receptor concentrations were the 
same in all tests, the differences between the mutations and the wild type reflect changes in hormone affinity. 
 
Scatchard plots were not suitable because the con-centration of the both receptors had to be determined and no 
ligand – a prerequisite for determination of receptor concentrations – is known for the orphan receptor so far. 
 
        
 
The C-Terminal Part of the Hinge Region and Helix 12 Is Required for Ligand Binding and Dimerization 
of the LBD 
Examination of deletion mutants [EcR(403–652), EcR (421 –652)] lacking parts of the D-domain demonstrate 
that not only the E-domain but also the C-terminal part of the hinge region is essential for hormone binding 
(Figure 6A, B) and ligand-dependent heterodimerization (Figure 6C). EcR (375 - – 642) shows that helix 12 is 
indispensable for both functions of the receptor. This means that the EcR(375–652) fragment chosen is the 
minimal sequence required for ligand binding and hormone-dependent heterodimerization. In all truncated 
versions, ligand binding is more seriously impaired in the case of EcR/USP as compared to EcR. This indicates 
that the in-creased hormone binding ability of the wild-type heterodimer is mediated at least partially by regions 
outside the canonical dimerization interface in helix 10. With EMSA, no ligand dependent formation of 
heterodimers is seen. 
 
Destruction of the Salt Bridge between H4 and H12 Impairs Ligand Binding to EcR, But Hormone 
Binding Is Partially Rescued by Heterodimerization with USP 
Not all amino acids of helix 12 are essential for receptor functions. Mutation of Glu at position 647 has only a 
minor effect on ligand binding to EcR; hormone binding of the heterodimer is in the normal range (Figure 7A, 
B). EMSA confirmed that ligand-dependent heterodimerization is not impaired (Figure 7C). In contrast, Glu648 
is important for hormone recognition by the EcR, but ligand binding of the heterodimer is reduced to a lesser 
degree (Figure 7A, B), indicating that heterodimerization compensates to a certain extent the deleterious effect 
of this mutation. This was confirmed by EMSA, which shows that heterodimerization in the presence of ligand 
is in the normal range (Figure 7C). 
 
In vertebrate nuclear receptors, there is a salt bridge from the conserved glutaminic acid in helix 12 to lysine in 
helix 4 (Wurtz et al., 1996). Mutation of Lys497 to alanine reduces ligand binding to EcR to a higher degree 
compared with EcR/USP. The electric charge is important for ligand binding of the heterodimer, since exchange 
of the basic amino acid by an acidic one in EcR
K497E
 diminishes ligand binding considerably (Figure 7A, B). 
According to EMSA, this is accompanied by insufficient dimerization. This indicates that Lys497 is involved in 
ligand binding and dimerization and may serve as a link to couple both functions. Disruption of the salt bridge 
alone is not responsible for this effect, since mutation of the second partner of the salt bridge E648 has only a 
moderate effect, although the charge of the amino acid was reversed. However, ligand binding to EcR is 
seriously impaired by mutation of both partners of the salt bridge. This may be a hint that not only the amino 
acids per se but also the integrity of the salt bridge is more important for ligand binding to EcR than for 
EcR/USP. 
 
Functional Role of Amino Acids Lining the Ligand-Binding Pocket 
Several amino acids are supposed to be involved in ligand binding according to the homology model presented 
by Wurtz et al. (2000). EcR
I463T
 does not impair ponasterone A binding to EcR and EcR/USP (Figure 8A, B), 
whereas EcR
E476A
 and EcR
D572S
 reduce ecdysteroid binding to EcR and the heterodimer to a considerable 
degree. Dimerization determined with EMSA is not affected (Figure 8C). M504 in helix 5 forms a hydrogen 
bond with the ligand according to the RAR based model (Wurtz et al., 2000). This amino acid is essential for 
hormone binding both to EcR and EcR/USP (Figure 8A, B), and is also important for ligand-dependent 
dimerization, which is abolished after mutation to arginine. EcR
R511
, which forms a hydrogen bond with 
hormone according to the VDR-model (Wurtz et al., 2000), nearly lost its capacity for ligand binding to EcR 
after mutation to glutamine (Figure 8A). Ligand-dependent heterodimerization (Figure 8C) and ponasterone A 
binding of EcR
R511Q
/USP is normal (Figure 8B) and indicates that the amino acid`s participation in ligand 
binding is different in EcR and EcR/USP. Hormone binding is rescued in the mutated receptor by interaction 
with the dimerization partner, as already shown for amino acids involved in the salt bridge H4-H12. 
 
Mutations Presumably Affecting the 3-D Architecture of the Ligand-Binding Pocket 
According to the homology model of Wurtz et al. (2000), amino acids at position 476, 553 and 572 have no 
direct contact to the ligand. Nevertheless, mutation of all three amino acids have an impact on ligand binding 
presumably by altering the 3-D architecture of the ligand-binding pocket (Figure 8). EcR
S553
 is another example 
of a suboptimal amino acid present in the wild type. The increase in ligand binding, however, is only observed 
with EcR, which demonstrates also that the conformation of the ligand-binding pocket is different in EcR and 
EcR/USP. 
    
Amino Acids in the Dimerization Interface (Helix 10) are Important for Ligand Binding to EcR/USP 
EcR
A612V
, EcR
L615A
, EcR
L615N
 and EcR
T619K
 do not show ligand-dependent heterodimerization in EMSA, in 
accordance with the essential role of helix 10 for dimerization (Figure 9C). In all mutations this is accompanied 
by reduced ligand binding to EcR/USP (Figure 9A, B). Elongation of the aliphatic side chain leads to steric 
hindrance in EcR
A612V
, whereas a shortened aliphatic side chain in EcR
L615A
 is not sufficient to allow efficient 
ligand-dependent heterodimerization. The length of the side chain seems to be more important than the 
hydrophilic proper-ties, since the introduction of asparagine at position 615 does not further impair the ligand 
binding in the presence of USP. 
 
The Same Mutation Can Affect Ligand Binding to EcR and EcR/USP Differently 
In addition to EcR
R511Q
 (Figure 8), several other mutations affect ligand binding to EcR and the heterodimer in 
opposite ways. Mutations of amino acids in the dimerization interface (helix 10) have a profound effect on 
ligand binding. The ability to bind hormone is seriously impaired in heterodimers with EcR
A612V
, EcR
L615A
, and 
EcR
L615N
 (Figure 9) and confirms the important role of these amino acids in dimerization. Ligand binding to 
these EcR mutants in the absence of USP is either not affected or increased. 
 
In contrast, I617 is involved in ligand binding to EcR, but the reduced capability for hormone binding in 
EcRI617A is compensated by heterodimerization. In EcR
I617A
, a hydrophobic interaction is interrupted due to 
the shortened side chain of alanine. However, exchange of isoleucine by a charged amino acid in EcR
I617K
 
impairs ligand binding also to the heterodimer. In contrast, introduction of a hydrophilic charged residue at 
position 619 even enhances ligand binding. This is most prominent for EcR, but is also seen with EcR/USP to a 
lesser degree. 
 
N626 is situated in the loop between helix 10 and helix 11. Mutation to either lysine or alanine revealed that this 
amino acid is mainly engaged in ligand binding, since heterodimerization is still possible according to results 
obtained by EMSA, and ligand binding is only considerably impaired to the heterodimer with EcR
N626A
. 
Hormone binding to EcR
N626A
 is only slightly reduced, but is considerably enhanced if the side chain is 
elongated by exchange of arginine with lysine, indicating that a suboptimal amino acid for hormone binding is 
present in the wild type. This is only apparent in ligand binding to EcR and not to the heterodimer. Since USP 
concentrations are critical for heterodimerization and hormone binding (Figure 4C), tests were repeated with 
higher USP concentrations to rule out the possibility that ligand binding to the heterodimer was underestimated 
due to insufficient USP concentrations. No increase was found with EcR
N626K
 (data not shown). These examples 
indicate that some amino acids are not optimal for ligand binding to the wild type but enable participation in a 
second receptor function (dimerization) at the expense of optimal ligand binding. They also clearly show that 
participation of individual amino acids differs in EcR and EcR/USP, thus demonstrating the allosteric effect of 
the heterodimerization partner. 
 
Discussion 
The general architecture of the ligand-binding domain, determined by X-ray analysis in nuclear receptors from 
vertebrates, revealed 11–12 helices and a ß-sheet arranged as an antiparallel sandwich (Wurtz et al., 1996). 
Prediction of the secondary structure using two different methods (Figure 2) showed that, despite of the low 
sequence identity (about 25% to RAR and VDR), basically the same structure was calculated for EcR. This was 
con-firmed by computer modeling of the ligand-binding pock-et using RAR and VDR as templates (Wurtz et 
al., 2000). This model allows prediction of ligand-binding properties in the middle of the ligand-binding 
domain, but the accuracy at the C- and N-termini is rather limited due to the low sequence similarity at both 
ends. 
 
Fusion proteins with GAL4 were used in our investigation for several reasons. Due to the presence of GAL4- 
DBD, the influence of ligand on dimerization mediated only by ligand-binding domains of EcR and USP is 
measured by EMSA. With the same fusions two hybrid experiments were performed using the same mutations 
to study the influence of hormone on reporter gene activity (Lezzi et al., 2002; Bergman et al., unpublished). 
These tests allow comparing the effect of receptor mutations on dimerization quantitatively. 
 
A tag is also essential for quantification of receptor concentrations by Western blotting, since no antibodies 
specific for the ligand-binding domain of EcR and USP are available. Quantification of receptor proteins is 
necessary; in order to rule out differences in the concentration of mutated proteins, which would lead to 
variations in the ligand binding tests. Scatchard analysis, which is traditionally used to eliminate the influence 
of variation in receptor concentration, cannot be used in the case of EcR/USP, because this method allows only 
determining the concentration of one receptor. 
 
For reliable determination of ecdysteroid binding to EcR/USP the concentration and the ratio of both receptors 
is important and has to be monitored carefully. Therefore quantification of signals on Western blots was chosen, 
which is also more accurate than Scatchard analysis. Only in this case a single hormone concentration is 
sufficient to determine differences in receptor affinity. 
The question remains whether the tag used for fusion with the receptor domains influences receptor proper-ties. 
The Kd values for full-length receptors EcR/USP and the corresponding fusion proteins are in the same range 
(M. Grebe, unpublished), therefore a major influence of the GAL4 moiety seems unlikely. This was also 
confirmed by comparison of purified Chironomus receptors with and without a GST-tag (Grebe and Spindler-
Barth, 2002) and with Drososphila receptors fused to GFP (M. Grebe, unpublished). In all cases the Kd values 
are in the same range independent of the presence or absence of the tag. Meanwhile in vivo experiments 
confirmed the functionality of the GAL4 fusions with EcR- and USP-LBDs (Kozlova and Thummel, 2002). We 
conclude that hormone binding to EcR is an autonomous function of the ligand-binding domain and is not 
influenced by intramolecular interactions. 
 
Drosophila ecdysteroid receptor dimerizes with USP in the absence of ligand (Yao et al., 1993) but binds also 
hormone in the absence of the heterodimerization partner (Bergman et al., unpublished; Lezzi et al., 2002). 
 
Interaction with either ligand or USP enhances binding of the third partner considerably. Ligand binding to EcR 
indicates that the ecdysteroid receptor alone, and not only EcR/USP, may be functional and offers the 
possibility of an additional regulatory pathway for molting hormones in Drosophila. The ability of EcR to bind 
ligands in the absence of USP is species specific, since hormone binding to purified ecdysteroid receptor from 
Chironomus necessiates the presence of USP (Grebe and Spindler-Barth, 2002). This means that CtEcR can act 
only as ligand-independent transcription factor in this species. We cannot discriminate between weak hormone 
binding to DmEcR due to diminished formation of homodimers, or due to an altered ligand-binding pocket of 
EcR that is allosterically modified by heterodimerization to enhance ligand binding. However, the fact that USP 
can restore or diminish hormone binding with some EcR mutants to a certain extent compared to ligand binding 
to EcR alone indicates allosteric interactions between both dimerization partners. In any case, the diverse effects 
of the same mutations on ligand binding to EcR and EcR/USP shows that the configuration of the ligand-
binding pocket is changed after heterodimerization. This is in accordance with vertebrate nuclear receptors; in 
RXR, the dimerization partner modifies the ligand binding of the corresponding partner to a high degree and 
thus allows or prohibits ligand binding (Glass, 1996). 
 
In contrast to full-length receptors (Antoniewski et al., 1996; Vögtli et al., 1998; Elke et al., 1999), 
heterodimerization in the absence of a ligand cannot be demonstrated with EMSA using GAL4-fusion proteins, 
but selectively al-lows determination of hormone-dependent heterodimerization. Basal dimerization of EcR and 
USP in the absence of hormone can only be measured with the yeast two-hybrid system (Lezzi et al., 2002). 
 
Truncations at either end of the ligand binding domain of EcR revealed that EcR (375–652) is the minimum 
sequence necessary for ligand binding. This means that the C-terminal half of the hinge region is also involved 
in ligand binding, although no direct contact to the ligand is possible. These results are in accordance with the 
data reported by Perera et al. (1999) obtained with Choristoneura EcR and are confirmed further by a mutation 
in the hinge region of EcR that was found in a hormone-resistant subclone of the Chironomus cell line (Zöllner, 
unpublished). In this case, full-length receptors were mutated to rule out reduction of ligand binding due to 
sterical hindrance, caused by the vicinity of the GAL4-moiety of the fusion protein. Prediction of the secondary 
structure (Spindler et al., 2001) revealed two additional helices in the C-terminal part of the hinge region, which 
may contribute to the stabilization of the 3 D-structure of the ligand-binding pocket. The hinge region and the 
N-terminal part of the E domain is the least conserved part of the ligand-binding region among insects. This 
leads us to assume that this region contributes to the species-specific differences in ligand binding and 
sensitivity to ecysteroids and diacylhdrazines (Dhadialla et al., 1998; Wurtz et al., 2000). 
 
Truncation of the C-terminal helix 12 in EcR abolishes ligand binding completely. This is in contrast to several 
vertebrate receptors that still show ligand binding after removal of helix 12, with a couple of the exceptions: 
TR, whose affinity to the ligand is decreased after truncation (Wagner et al., 1995), and AR, which has lost 
binding capacity completely after mutation of an amino acid adjacent to H12 (Peters et al., 1999). This 
illustrates that, although the architecture of the ligand-binding domain is very similar in all nuclear receptors 
investigated so far, the function of individual receptor domains is different. Helix 12 mediates ligand-dependent 
transactivation, induced by a change in the position of helix 12 after ligand binding and stabilization by a salt 
bridge between Glu648 in helix 12 and Lys497 in helix 4. Interruption of the salt bridge by mutation of either 
Lys497 or Glu648 nearly abolishes ligand binding to EcR. In opposition to the reduced ligand binding of EcR 
after mutation of Lys497 and Glu648, which is impaired to about the same degree, hormone binding of the 
heterodimer is only mildly affected in EcR
E648K
. This shows that the lysine is essential for ligand binding to EcR 
and EcR/USP, but maintenance of the salt bridge is more important for ligand binding to EcR than to the 
heterodimer. Therefore, we assume that heterodimerization compensates partially for the loss of stabilization by 
the salt bridge. The allosteric effect of either USP or ligand to improve binding of the third partner can be 
explained by the stabilization of the same 3-D structure of the receptor complex by a salt bridge, or by 
heterodimerization. 
 
Mutations of amino acids presumably lining the ligand-binding pocket lead to different changes in the 
functionality of this receptor domain. As shown in this report, EcR
I463T
 in Drosophila impairs ponasterone A 
binding only slightly, whereas in EcR of a hormone-resistant subclone of the Chironomus cell line isoleucine 
changed to leucine at the corresponding position is associated with a loss of hormone binding (Zöllner, 
unpublished; Grebe et al., 2000). Interestingly, the corresponding isoleucine is changed to threonine in wild-
type EcR of Tenebrio (Mouillet et al., 1997). However, no ligand binding data are available from this species. 
Although ligand binding is more impaired in EcR
E476A
 and EcR
D572S
, hormone-dependent dimerization is still 
possible. As expected, ligand-de-pendent dimerization is also abolished in a mutated receptor that cannot bind 
ecdysteroids any more like EcR
M504R
. In contrast, defective ligand binding of EcR
R511Q
 can be rescued by 
dimerization. Arginine at position 511 is a very conserved amino acid, which mediates hormone binding by the 
formation of a hydrogen bond with the ligand also in vertebrate nuclear receptors like progesterone receptor 
(Letz et al., 1999). Mutation of this amino acid clearly demonstrates the interdependence of different receptor 
functions. 
 
According to the homology model presented by Wurtz et al. (2000), the amino acids at positions 476, 553 and 
572 are solvent exposed and cannot contact the ligand directly. Nevertheless, either reduced ligand binding is 
observed after mutation (EcR
E476A
, EcR
D572S
), or hormone binding to EcR is enhanced in the absence of USP 
(EcR
S553A
). We speculate that these effects are indirect and are due to changes in the architecture of the ligand-
binding pocket. 
 
Helix 10 is important for dimerization (Bourget et al., 1995). This region is rich in leucine and other 
hydrophobic amino acids both in EcR and USP, although a typical leucine zipper motif or LXXLL sequence is 
missing. The mutants EcR
A612V
, EcR
L615A
 and EcR
L615N
 confirm the importance of hydrophobic interactions for 
dimerization. The elongation of the hydrophobic amino acid residue in A612V impairs dimerization by steric 
hindrance. In contrast, replacement of alanine by glutamine in Bombyx mori EcR enhances dimerization (Suhr 
et al., 1998). The length of the hydrophobic site chain is also important for L615 in contrast to EcR
I617A
. In this 
case, replacement by a charged amino acid is necessary to impair dimerization. 
 
Besides these more or less specific effects on ligand binding and dimerization observed after mutation of a 
single amino acid, we have to be aware that changes in the general architecture of the ligand-binding pocket 
may also contribute to the differences in receptor function. This is most prominent for the D-domain, which has 
no direct contact to the ligand and the solvent exposed amino acids at positions 476, 553 and 572. It may also 
contribute to the effects described for other point mutations. These general effects will be described in detail by 
Bergman et al. (unpublished). 
 
Generally, ponasterone A binding to the heterodimers goes in parallel with ligand dependent heterodimerization 
measured with EMSA, confirming that the same complex is measured with both methods. We never observed 
ligand binding significantly exceeding that of wild-type heterodimers. However, considerably enhanced 
galactosidase induction was found both in the absence and in the presence of hormone in the two-hybrid system 
(EcR
K497A
 and EcR
I617E
, EcR
S553E
 , EcR
D572S
, EcR
T619A
 and EcR
T619K
, EcR
N626A
 and EcR
N626K
) (Bergmann et al., 
unpublished) and indicates that additional factors in the yeast cell modify either the interaction between both 
receptors and their trans-activation. 
 
In contrast, enhanced ligand binding to mutated EcR compared to the wild type was found several times. In 
EcR
L615A
, EcR
L615N
, and EcR
T619K
 increased hormone binding to EcR is accompanied by impaired 
heterodimerization. Obviously reduced affinity to wild-type EcR is accepted in order to enable the mediation of 
both functions by the same amino acid. This demonstrates that enhanced flexibility of hormonal regulation by 
coupling of the two receptor functions is preferred over an optimal single function. 
 
Different effects of the same mutation, e.g. EcR
R511Q
, EcR
N626K
, and EcR
E648K
, on ligand binding to EcR and 
EcR/USP show that the contribution of the same amino acid in ligand binding to EcR in the presence and 
absence of USP is not identical. This means that the 3-D structure of the ligand-binding pocket is changed by 
heterodimerization. The diverse effects of amino acids outside the dimerization interface on hormone binding to 
EcR and the heterodimer with USP indicate conformational changes of major parts of the ligand-binding pocket 
induced by heterodimerization, and are in accordance with the changes in the 3-D structure reported for 
apoRXR and holoRAR (Bourget et al., 1995; Renaud et al., 1995). 
 
Wurtz et al. (2000) described homology models using RAR and VDR as templates, which define amino acids 
lining the ligand-binding pocket. Our results basically confirm the proposed model for hormone binding, but 
demonstrate that several additional amino acids are en-gaged in hormone binding as well. This involves mainly 
amino acids at the dimerization interface in helix 10, and the salt bridge and the AF2 domain in helix 12. In 
addition, it was shown that some amino acids lining the binding-binding pocket or situated in helix 10, which is 
sup-posed to be involved in dimerization, are engaged in both receptor functions. 
 
Ligand binding is a dynamic process. The high dissociation rate constants (Yund et al., 1978; Turberg et al., 
1988) between hormone and ecdysteroid receptor show that the intra- and intermolecular allosteric interactions 
associated with ligand binding are easily reversible. Kosztin et al. (1999) calculated that the main pathways for 
ligand entry and ligand exit were different in RAR. Both paths do not involve helix 12. 20-OH-ecdysone, the 
most important naturally occurring ligand of the ecdysteroid receptor, has no charge like retinoic acid and is 
much more hydrophilic than vitamin D. These properties will certainly affect the mechanism of hormone 
binding. In contrast, ligand binding to EcR depends on the participation of helix 12 and the amino acids 
involved in the salt bridge. This points to a different mechanism for association and dissociation of ligands to 
the ecdysteroid receptor compared to the RAR-based model of Kosztin et al. (1999), and is currently under 
investigation. 
 
Materials and Methods 
Yeast Strain 
Saccharomyces cerevisiae strain Y190 (Harper et al., 1993) was cultured according to the manufacturer 
(Clontech yeast protocols handbook PT3024-1; Clontech Laboratories, USA). Yeast transformation was 
performed with lithium acetate (Guthrie et al., 1991). Transformants were selected by auxotrophy for 
tryptophan (pAS2-1) and leucine (pACT2), respectively. 
 
Construction of Yeast Expression Plasmids 
DNA encoding the C-terminal part of the D-domain and the E-domain (LBD) of Drosophila ecdysteroid 
receptor was cloned into the expression vector pACT2 (Li et al., 1994), resulting in a Gal4(AD)-EcR(LBD) 
(AD: activating domain) fusion protein. For expression of Gal4(DBD)-USP(LBD) (DBD: DNA binding 
domain) the C-terminal part of the D-domain and the E-domain of Drosophila ultraspiracle (Figure 1) was 
cloned into the vector pAS2-1 (Harper et al., 1993). GAL4 expression plasmids and the corresponding plasmids 
with EcR and USP wild type and mutants created by site-directed mutagenesis were kindly provided by Dr. 
Lezzi (ETH Zürich, Switzerland). 
 
Preparation of Yeast Extracts 
Single colonies (not older than 4 days) of yeast transformants carrying the expression plasmids either for Gal4-
AD-EcR or GAL4-DBD-USP wild types or the corresponding mutants were picked and cultured at 30°C 
overnight in 5 ml selective medium containing 2% glucose with shaking (150–200 rpm). The overnight cultures 
were vigorously shaken to disperse the cells thoroughly, diluted in 50 ml YPD medium (20 g/l peptone, 10 g/l 
yeast extract, 2% glucose) and grown under the same conditions until the OD600 reached 0.6 to 0.8. If not 
stated otherwise, the following steps of preparation were done on ice. Yeast cells were harvested by 
centrifugation (1500 g, 5 min, 4°C) in prechilled tubes. Cell pellets were washed with 50 ml ice-cold wash 
buffer (20 mM HEPES, 20 mM NaCl, 20% glycerol, 1 mM EDTA, 1 mM 2-mercaptoethanol, pH 7.9) and 
transferred into plastic tubes, supplemented with a steel ball and frozen in liquid nitrogen for about 20 s. The 
frozen pellets were disrupted for 2 min at 2000 rpm using a Micro-dismembrator S (B. Braun Biotech 
International, Melsungen, Germany). After thawing homogenates were diluted with binding buffer [20 mM 
HEPES, 20 mM NaCl, 20% glycerol, 1 mM EDTA, 1 mM 2-mercap-toethanol, 1 mM phenylmethylsulfonyl 
fluoride (PMSF), pH 7.9] supplemented with a mixture of protease inhibitors (aprotinin, leupeptin, pepstatin, 
benzamidine, antipain, chymostatin; final concentration 2 µg/ml each) immediately before use. After short 
treatment with ultrasonic power (Branson Sonifier, B-12, Bran-son, Danbury, USA) using a microtip (2 × 2 s, 
90 W) the samples were centrifuged (100 000 g, 1 h, 4 °C). PMSF (final concentration 1 mM) was added to the 
supernatants. The extracts were frozen in aliquots at –80°C until use for ligand binding assays, Western blot 
analysis and electrophoretic mobility shift assays (EMSA). 
 
Western Blot and Quantitative Determination of EcR and USP Fusion Proteins 
Yeast cell extracts were diluted with sample buffer (final concentration 100 mM Tris, 3% SDS, 2% 2-
mercaptoethanol, 10% glycerol, 0.05% bromophenol blue, pH 8.8) and boiled for 3 min (Laemmli, 1970). 10–
20 µg protein per lane (Bradford, 1976) were loaded onto a SDS-gel (0.6× MDE gel solution, Boehringer, 
Ingelheim, Germany; AT Biochem., Minigel Twin, 8.6×7.2× 0.1 cm, Biometra, Göttingen, Germany). Western 
blotting was performed according to Khyse-Andersen (1984). Gels were electroblotted on nitrocellulose 
membranes (BA 85, 45 µm pore size, Schleicher and Schuell, Dassel, Germany). The membranes were soaked 
in blocking buffer (5% milk powder, 1 % fat in 20 mM Tris-HCl, 137 mM NaCl, 0.1 % Tween 20, pH 7.6, 
0.02% Thimerosal) and probed either with Gal4-AD monoclonal mouse antibody (# 5398 – 1, Clontech 
Laboratories) or Gal4-DBD polyclonal rabbit antibody (# sc-577, Santa Cruz Biotechnology Inc, Santa Cruz, 
USA) diluted in blocking buffer 1:5000 (Gal4-AD) and 1:100 (Gal4-DBD), respectively. To detect specific 
Western signals per-oxidase conjugated secondary antibodies diluted in TBS (0.1 % Tween 20) were used 
(1:1000 anti-mouse IgG, or 1:500 anti-rabbit IgG, both from Sigma). After visualization with an ECL detection 
kit (Amersham) according to the instructions of the supplier specific signals were scanned (Scanner JX-325, 
Sharp, 600 dpi, software ViceVersa Scan 1.2, Krystec EDV, Norderstedt, Germany) and analyzed with an 
image analysis system (PHORETIX, Nonlinear Dynamics, LTD, Newcaste, UK; resolution 600 dpi, 
corresponding to 42 µm2). The intensity of a given band was quantified and taken as measure for EcR or USP 
concentration. The linearity was previously verified by calibration (Rauch et al., 1998). 
 
Ligand Binding Assays 
Yeast cell extracts were diluted to an appropriate protein con-centration (Bradford, 1976) with binding buffer 
and supplemented with protease inhibitors (see above) immediately before use. Ligand binding was determined 
with [
3
H]-ponasterone A (specific activity 7.9 TBq/mmol; kind gift of Dr. H. Kayser, Syngenta, Switzerland) 
using a filter assay as already described in detail (Turberg and Spindler, 1992) The appropriate amounts of yeast 
extracts with EcR and USP fusion proteins (determined by quantification of Western blot signals) were mixed 
together and incubated with 4 – 5 nM [
3
H]-ponasterone A for 1 h at room temperature. For each sample the 
nonspecific binding determined by addition of 0.1 mM non-labeled 20-OH-ecdysone was subtracted. The purity 
of [
3
H]-ponasterone A was checked routinely by HPLC analysis before use. Routinely two different extracts 
were tested in duplicate. Ligand binding data of mutated receptors were expressed as % of wild type hormone 
binding (= 100%). 
 
Electrophoretic Mobility Shift Assay (EMSA) 
The oligonucleotides dgal 1 (5’-GATCGCACAGTGCCGGAG-GACAGTCCTCCGGTTCGAT-3’) and dgal 
(5’-GATCATCGAAC-CGGAGGACTGTCCTCCGGCACTGTGC3’) were formed by annealing 5’-extensions 
with the sequence GATC labeled with [α-
32
P]-dCTP by fill-in reaction with Klenow polymerase. The labeled 
oligonucleotides were used as probe for binding to the fusion proteins. 
 
The reaction mix contained binding buffer [20 mM HEPES, pH 7.4, 100 mM KCl, 5% (v/v) glycerol, 2 mM 
dithiothreitol, 0.1 % NP-40], yeast cell extracts with the EcR or USP fusion proteins, 1 µg non-specific 
competitor poly(dIdC) and approximately 10 fmol labeled oligonucleotide. 10
–5
 M muristerone A (final con-
centration) was used, where indicated. The reaction mix was incubated at room temperature for 30 min and 
separated at 10 V/cm on a 5% nondenaturing polyacrylamide gel in 0.5× TBE (45 mM Tris, 45 mM boric acid, 
0.5 mM EDTA, pH 8.0) for 2 h. Gels were dried, scanned with a Phosphorimager and evaluated with 
ImageQuantTM software package (Molecular Dynamics, Sunnyvale, USA). 
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